Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sophiris Bio Inc (NASDAQ:SPHS)

2.01
Delayed Data
As of Jun 28
 +0.29 / +16.86%
Today’s Change
0.67
Today|||52-Week Range
3.85
+12.92%
Year-to-Date
No recent news for Sophiris Bio Inc.

Today’s Trading

Previous close1.72
Today’s open1.74
Day’s range1.73 - 2.10
Volume1,305,332
Average volume (3 months)901,347
Market cap$41.8M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+54.59%
Earnings growth (this year)+13.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book18.19

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...+0.08+5.44%
SNTASynta Pharmaceutical...+0.02+7.49%
IPCIIntellipharmaceutics...-0.01-0.65%
EBIOEleven Biotherapeuti...+0.03+1.57%
Data as of 06/28/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$14.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Randall E. Woods
COO, Head-Research &
Development
Allison J. Hulme
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers

Search for Jobs